Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. (Q49141439)
Jump to navigation
Jump to search
scientific article published in February 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. |
scientific article published in February 1996 |
Statements
1 reference
Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. (English)
1 reference
D Fulton
1 reference
R Urtasun
1 reference
P Forsyth
1 reference
1 February 1996
1 reference
1 reference
27
1 reference
2
1 reference
149-155
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference